Pancreatic Cancer Research

ResearcherStanford MedicineActive in the last 2 years

Julien Sage

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-8928-9968; OpenAlex author ID A5073510275. Sources: OpenAlex.

Their work

Papers
7 (first author 1, last author 1)
Trials
0
Grants
0
Labs led
1
Collaborators
32
Papers, trials and grants by year

2015: 2 papers · 2016: 1 paper · 2017: 1 paper · 2018: none · 2019: none · 2020: 1 paper · 2021: none · 2022: none · 2023: none · 2024: 1 paper · 2025: none · 2026: 1 paper

Papers 7

  1. Author Correction: Combined inhibition of BET family proteins and histone deacetylases as a potential epigenetics-based therapy for pancreatic ductal adenocarc… Co-author DOI 10.1038/s41591-026-04234-8↗
  2. Author Correction: Combined inhibition of BET family proteins and histone deacetylases as a potential epigenetics-based therapy for pancreatic ductal adenocarc… Co-author DOI 10.1038/s41591-024-03054-y↗
  3. SETD5-Coordinated Chromatin Reprogramming Regulates Adaptive Resistance to Targeted Pancreatic Cancer Therapy. Co-author DOI 10.1016/j.ccell.2020.04.014↗
  4. An integrative approach unveils FOSL1 as an oncogene vulnerability in KRAS-driven lung and pancreatic cancer. Co-author DOI 10.1038/ncomms14294↗
  5. Coordination of stress signals by the lysine methyltransferase SMYD2 promotes pancreatic cancer. Last author DOI 10.1101/gad.275529.115↗
  6. Combined inhibition of BET family proteins and histone deacetylases as a potential epigenetics-based therapy for pancreatic ductal adenocarcinoma. Co-author DOI 10.1038/nm.3952↗
  7. Pancreatic cancer takes its Toll. First author DOI 10.1084/jem.21212insight1↗

Closest collaborators

The 25 strongest of 32 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Pawel Karol Mazur · 7 shared papers, 2015–2026 · strength 0.66
  2. Simone Hausmann · 4 shared papers, 2015–2026 · strength 0.46
  3. Marija Trajkovic‐Arsic · 3 shared papers, 2015–2026 · strength 0.37
  4. Stephano S. Mello · 3 shared papers, 2015–2026 · strength 0.37
  5. Mert Erkan · 3 shared papers, 2015–2026 · strength 0.37
  6. Bence Sipos · 3 shared papers, 2015–2026 · strength 0.37
  7. Irina Heid · 3 shared papers, 2015–2026 · strength 0.37
  8. Stephan A. Hahn · 3 shared papers, 2015–2026 · strength 0.37
  9. Alexander Herner · 3 shared papers, 2015–2026 · strength 0.37
  10. Roland Michael Schmid · 3 shared papers, 2015–2026 · strength 0.37
  11. Jens Thomas Siveke · 3 shared papers, 2015–2026 · strength 0.37
  12. Iréne Esposito · 3 shared papers, 2015–2026 · strength 0.37
  13. Elisabeth Heßmann · 3 shared papers, 2015–2026 · strength 0.37
  14. Jorg H. Kleeff · 3 shared papers, 2015–2026 · strength 0.37
  15. Laura D Attardi · 3 shared papers, 2015–2026 · strength 0.37
  16. Rickmer Braren · 3 shared papers, 2015–2026 · strength 0.37
  17. Matthias Wirth · 3 shared papers, 2015–2026 · strength 0.37
  18. Volker Ellenrieder · 3 shared papers, 2015–2026 · strength 0.37
  19. Tyler Jacks · 3 shared papers, 2015–2026 · strength 0.37
  20. Or P. Gozani · 2 shared papers, 2016–2020 · strength 0.13
  21. Huamin Wang · 1 shared paper, 2020 · strength 0.08
  22. Michael P. Kim · 1 shared paper, 2020 · strength 0.08
  23. Anirban Maitra · 1 shared paper, 2020 · strength 0.08
  24. Zhentian Wang · 1 shared paper, 2020 · strength 0.08
  25. Adrián Vallejo · 1 shared paper, 2017 · strength 0.05

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.